Regulation of m⁶A (N⁶-Methyladenosine) methylation modifiers in solid cancers

Area of Science:

• Molecular Oncology
• Epigenetics
• RNA Biology

Background:

• Solid cancers present a significant global health challenge, necessitating a deeper understanding of their molecular underpinnings.
• N-methyladenosine (m6A) RNA methylation is an epigenetic modification increasingly recognized for its role in solid tumor biology.
• Dysregulation of m6A patterns is observed across various solid tumors, impacting key cancer-related genes and processes.

Purpose of the Study:

• To explore the role of m6A RNA methylation in the development and progression of solid tumors.
• To investigate the mechanisms by which m6A modification influences gene expression and cellular processes in cancer.
• To evaluate the therapeutic potential of targeting m6A regulators in solid tumors.

Main Methods:

• Analysis of m6A modification patterns in various solid cancer types.
• Investigation of the roles of m6A 'writers', 'erasers', and 'readers' in cancer.
• Review of emerging therapeutic strategies targeting m6A regulators.

Main Results:

• m6A modification patterns are significantly altered in solid tumors.
• Dysregulated m6A impacts oncogenes, tumor suppressors, cancer stem cells, metastasis, and treatment resistance.
• The interplay of m6A regulators (writers, erasers, readers) shapes the tumor methylome.

Conclusions:

• m6A RNA methylation is a critical epigenetic mechanism in solid tumor progression.
• Targeting m6A regulators represents a promising novel therapeutic avenue for cancer treatment.
• Restoring or altering m6A patterns holds potential for improving treatment outcomes in solid tumors.